| 5' Cap |
130 |
Microbial Genetics |
| Acid |
21 |
Foundations |
| Acid-Fast Cell Walls |
35, 39, 51 |
Foundations; Prokaryote & Eukoaryote Cells |
| Acid-Fast Stain |
35, 39 |
Foundations |
| Acidic Dye |
34 |
Foundations |
| Acidophiles |
113 |
Microbial Growth |
| Acne |
370 |
Infections- Skin & Eye System |
| Acquired Immodeficiency Syndrome (AIDS) |
323 |
Infections- Cardiovascular System |
| Acquired Immunity |
220, 230 - 245 |
Disease, Immunity & Epidemiology |
| Activator |
147 |
Microbial Genetics |
| Active Artificial Immunity |
244 |
Disease, Immunity & Epidemiology |
| Active Natural Immunity |
244 |
Disease, Immunity & Epidemiology |
| Active Site |
78 - 81 |
Microbial Metabolism |
| Active Transport |
67 |
Prokaryote & Eukoaryote Cells |
| Acute Disease |
209 |
Disease, Immunity & Epidemiology |
| Acute Phase Proteins |
223 |
Disease, Immunity & Epidemiology |
| Adenosine Triphosphate (ATP) |
76 |
Microbial Metabolism |
| Adherence Factors |
218 |
Disease, Immunity & Epidemiology |
| Adpative Immunity |
220, 230 - 245 |
Disease, Immunity & Epidemiology |
| Aeorbic Respiration |
83 - 91, 93 |
Microbial Metabolism |
| Aerotolerant Anaerobes |
110 - 111 |
Microbial Growth |
| African Trypanosomiasis |
338 |
Infections- Nervous System |
| Agarose Gel Electrophoresis |
159 - 160 |
Microbial Genetics |
| Agglutination |
234 |
Disease, Immunity & Epidemiology |
| Agglutination Test |
181, 251 |
Acellular Infectious Agents; Disease, Immunity & Epidemiology |
| Agranulocytes |
226 |
Disease, Immunity & Epidemiology |
| Airborne Transmission |
214 |
Disease, Immunity & Epidemiology |
| Alcohol Fermentation |
92 - 93 |
Microbial Metabolism |
| Alcohols |
188 |
Control of Microbial Growth |
| Algae |
12 |
Foundations |
| Alkalating Agents |
189 |
Control of Microbial Growth |
| Alkaline |
21 |
Foundations |
| Alkaliphiles |
113 |
Microbial Growth |
| Allosteric Inhibitor |
80 |
Microbial Metabolism |
| Alternative Pathway (Complement Activation) |
224 |
Disease, Immunity & Epidemiology |
| Amensalism |
216 |
Disease, Immunity & Epidemiology |
| American Trypanosomiasis |
326 |
Infections- Cardiovascular System |
| Ames Test |
141 |
Microbial Genetics |
| Aminoglycosides |
194 |
Control of Microbial Growth |
| Anabolism |
74 |
Microbial Metabolism |
| Anaerobic Respiration |
83 - 93 |
Microbial Metabolism |
| Analytical Epidemiology |
256 |
Disease, Immunity & Epidemiology |
| Anion |
17 |
Foundations |
| Anoxygenic Photosynthesis |
96 |
Microbial Metabolism |
| Antagonism |
192 |
Control of Microbial Growth |
| Anthrax |
374 |
Infections- Skin & Eye System |
| Antibiotic Resistance |
201 - 202 |
Control of Microbial Growth |
| Antibody |
231 - 234 |
Disease, Immunity & Epidemiology |
| Antibody Classes |
233 |
Disease, Immunity & Epidemiology |
| Antibody-Dependent Cell-Mediated Cytotoxicity |
234 |
Disease, Immunity & Epidemiology |
| Antifungal Medications |
199 |
Control of Microbial Growth |
| Antigen |
231 - 232, 234 |
Disease, Immunity & Epidemiology |
| Antigen-Antibody Interactions |
234 |
Disease, Immunity & Epidemiology |
| Antigen-Presenting Cell (APC) |
226, 235 |
Disease, Immunity & Epidemiology |
| Antigenic Variation |
218 |
Disease, Immunity & Epidemiology |
| Antihelminthic Medications |
198 |
Control of Microbial Growth |
| Antimicrobial Peptides |
223 |
Disease, Immunity & Epidemiology |
| Antiprotozoal Medications |
198 |
Control of Microbial Growth |
| Antisepsis |
183 |
Control of Microbial Growth |
| Antiviral Medications |
199 |
Control of Microbial Growth |
| Apoenzyme |
78 - 79 |
Microbial Metabolism |
| Apoptosis |
226, 238 |
Disease, Immunity & Epidemiology |
| Arboviral Encephalitis |
333 |
Infections- Nervous System |
| Archaea |
6, 10 |
Foundations |
| Ascaris lumbricoides |
258 |
Microbes |
| Aspergillosis |
308 |
Infections- Respiratory System |
| Aspergillus spp. |
258 |
Microbes |
| Asymptomatic |
205 |
Disease, Immunity & Epidemiology |
| Atomic Structure |
16 |
Foundations |
| Autoclave |
185 |
Control of Microbial Growth |
| Autoimmune Disorder |
246 |
Disease, Immunity & Epidemiology |
| Autotroph |
82 |
Microbial Metabolism |
| B Cells |
230, 236 - 237 |
Disease, Immunity & Epidemiology |
| Bacillary Dysentery |
345 |
Infections- Gastrointestinal System |
| Bacillus |
42, 44 |
Prokaryote & Eukoaryote Cells |
| Bacillus anthracis |
258 |
Microbes |
| Bacterial Growth Curve |
100 |
Microbial Growth |
| Bacterial Growth Phases |
99 |
Microbial Growth |
| Bacterial Safety Levels (BSLs) |
204 |
Control of Microbial Growth |
| Bacterial Vaginosis (BV) |
362 |
Infections- Genitourinary System |
| Bactericidal |
191 |
Control of Microbial Growth |
| Bacteriophage |
164, 168 - 173, 181 |
Acellular Infectious Agents |
| Bacteriostatic |
191 |
Control of Microbial Growth |
| Bartonella henselae |
259 |
Microbes |
| Base |
21 |
Foundations |
| Basic Dye |
34 |
Foundations |
| Basic Reproduction Number |
255 |
Disease, Immunity & Epidemiology |
| Basophils |
226 |
Disease, Immunity & Epidemiology |
| Bilharzia |
327 |
Infections- Cardiovascular System |
| Binary Fission |
97 - 98 |
Microbial Growth |
| Biofilms |
108 |
Microbial Growth |
| Biogenesis |
1 |
Foundations |
| Biogeochemical Cycles |
116 - 119 |
Microbial Growth |
| Biological Vector |
214 |
Disease, Immunity & Epidemiology |
| Bionomial Nomenclature |
5 |
Foundations |
| Biotechnology |
153 - 163 |
Microbial Genetics |
| Bisbiguanides |
189 |
Control of Microbial Growth |
| Blue-White Screening |
158 |
Microbial Genetics |
| Blunt Ends |
154 - 155 |
Microbial Genetics |
| Bordetella pertussis |
259 |
Microbes |
| Borrelia burgdorferi |
259 |
Microbes |
| Botulism |
330 |
Infections- Nervous System |
| Bridge Reaction |
86 |
Microbial Metabolism |
| Brightfield Microscope |
29 - 30 |
Foundations |
| Broad-Spectrum |
191 |
Control of Microbial Growth |
| Brucella spp. |
260 |
Microbes |
| Brucellosis |
312 |
Infections- Cardiovascular System |
| Bubonic Plague |
314 |
Infections- Cardiovascular System |
| Burst |
179 - 180 |
Acellular Infectious Agents |
| Burst Size |
179 - 180 |
Acellular Infectious Agents |
| Calvin Cycle |
95 |
Microbial Metabolism |
| Campylobacter jejuni |
260 |
Microbes |
| Campylobacteriosis |
350 |
Infections- Gastrointestinal System |
| Candida albicans |
260 |
Microbes |
| Capnophiles |
110 |
Microbial Growth |
| Capsid |
165 |
Acellular Infectious Agents |
| Capsule |
35, 40, 53, 218 |
Foundations; Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
| Capsule Stain |
35, 40 |
Foundations |
| Carbapenems |
193 |
Control of Microbial Growth |
| Carbohydrates |
25 |
Foundations |
| Carbon Cycle |
116 |
Microbial Growth |
| Carrier |
212 |
Disease, Immunity & Epidemiology |
| Cat Scratch Disease |
313 |
Infections- Cardiovascular System |
| Catabolism |
74 |
Microbial Metabolism |
| Cation |
17 |
Foundations |
| Cell Shapes & Configurations |
42 - 44 |
Prokaryote & Eukoaryote Cells |
| Cell Wall Inhibitors |
193 |
Control of Microbial Growth |
| Cell Walls |
51 - 52, 63 |
Prokaryote & Eukoaryote Cells |
| Cellular Immunity |
230, 238 - 242 |
Disease, Immunity & Epidemiology |
| Cellular Respiration |
83 - 93 |
Microbial Metabolism |
| Centers for Disease Control (CDC) |
257 |
Disease, Immunity & Epidemiology |
| Central Dogma of Molecular Biology |
123 |
Microbial Genetics |
| Centrosomes |
59 |
Prokaryote & Eukoaryote Cells |
| Cephalosporins |
193 |
Control of Microbial Growth |
| Chagas Disease |
326 |
Infections- Cardiovascular System |
| Chemical Bonds |
18 |
Foundations |
| Chemical Fixation |
33 |
Foundations |
| Chemical Food Preservatives |
189 |
Control of Microbial Growth |
| Chemical Mutagens |
138 |
Microbial Genetics |
| Chemical Reactions |
73 - 75 |
Microbial Metabolism |
| Chemically Defined Media |
114 |
Microbial Growth |
| Chemiosmosis |
89 - 91 |
Microbial Metabolism |
| Chemotroph |
82 |
Microbial Metabolism |
| Chickenpox |
304 |
Infections- Respiratory System |
| Chikungunya Fever |
321 |
Infections- Cardiovascular System |
| Chlamydia |
364 |
Infections- Genitourinary System |
| Chlamydia trachomatis |
261 |
Microbes |
| Chloroplasts |
62, 65 - 66 |
Prokaryote & Eukoaryote Cells |
| Cholera |
349 |
Infections- Gastrointestinal System |
| Chromatin |
58 |
Prokaryote & Eukoaryote Cells |
| Chromophore |
34 |
Foundations |
| Chromosomes |
58 |
Prokaryote & Eukoaryote Cells |
| Chronic Disease |
209 |
Disease, Immunity & Epidemiology |
| Chronic Viral Infection |
178 |
Acellular Infectious Agents |
| Cilia |
64, 221 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
| Citric Acid Cycle |
87 - 88 |
Microbial Metabolism |
| Classical Pathway (Complement Activation) |
224 |
Disease, Immunity & Epidemiology |
| Clostridioides difficile |
261 |
Microbes |
| Clostridioides difficile Infection |
353 |
Infections- Gastrointestinal System |
| Clostridium botulinum |
262 |
Microbes |
| Clostridium difficle |
261 |
Microbes |
| Clostridium difficle Infection |
353 |
Infections- Gastrointestinal System |
| Clostridium perfringens |
262 |
Microbes |
| Clostridium perfringens Gastroenteritis |
352 |
Infections- Gastrointestinal System |
| Clostridium tetani |
262 |
Microbes |
| Coccidioides immitis |
263 |
Microbes |
| Coccidioidomycosis |
307 |
Infections- Respiratory System |
| Coccobacillus |
42 |
Prokaryote & Eukoaryote Cells |
| Coccus |
42 - 43 |
Prokaryote & Eukoaryote Cells |
| Codons |
131 - 132 |
Microbial Genetics |
| Coenzyme |
78 - 79 |
Microbial Metabolism |
| Cofactor |
78 - 79 |
Microbial Metabolism |
| Cold Sores |
378 |
Infections- Skin & Eye System |
| Commensalism |
216 |
Disease, Immunity & Epidemiology |
| Commerical Sterilization |
183 |
Control of Microbial Growth |
| Common Cold |
298 |
Infections- Respiratory System |
| Common Source Spread |
253 |
Disease, Immunity & Epidemiology |
| Communicable Disease |
206 |
Disease, Immunity & Epidemiology |
| Competitive Inhibitor |
80 - 81 |
Microbial Metabolism |
| Complement Activation |
224, 234 |
Disease, Immunity & Epidemiology |
| Complement Fixation Test |
251 |
Disease, Immunity & Epidemiology |
| Complement System |
224 - 225 |
Disease, Immunity & Epidemiology |
| Complex Media |
114 |
Microbial Growth |
| Confocal Microscope |
32 |
Foundations |
| Conjugate Vaccine |
245 |
Disease, Immunity & Epidemiology |
| Conjugation |
142 - 145 |
Microbial Genetics |
| Conjunctivitis |
376 |
Infections- Skin & Eye System |
| Contagious Disease |
206 |
Disease, Immunity & Epidemiology |
| Contrast |
28 |
Foundations |
| Coronavirus Disease 2019 |
301 |
Infections- Respiratory System |
| Corynebacterium diphtheriae |
263 |
Microbes |
| Covalent Bond |
18 |
Foundations |
| COVID-19 |
301 |
Infections- Respiratory System |
| Crenation |
69 |
Prokaryote & Eukoaryote Cells |
| Creutzfeldt-Jakob Disease |
337 |
Infections- Nervous System |
| CRISPR |
161 |
Microbial Genetics |
| Cryptococcus neoformans |
263 |
Microbes |
| Cryptosporidiosis |
357 |
Infections- Gastrointestinal System |
| Cryptosporidium spp. |
264 |
Microbes |
| Culture Medium |
114 |
Microbial Growth |
| Cutibacterium acnes |
264 |
Microbes |
| Cysticercosis |
339 |
Infections- Nervous System |
| Cystitis |
360 |
Infections- Genitourinary System |
| Cytokines |
223 |
Disease, Immunity & Epidemiology |
| Cytomegalovirus |
264 |
Microbes |
| Cytomegalovirus Disease |
318 |
Infections- Cardiovascular System |
| Cytopathic Effects |
181 |
Acellular Infectious Agents |
| Cytoplasm |
46, 59 |
Prokaryote & Eukoaryote Cells |
| Cytoskeleton |
59 |
Prokaryote & Eukoaryote Cells |
| Cytotoxic T Cells |
238, 241 - 242 |
Disease, Immunity & Epidemiology |
| Dark Repair |
139 |
Microbial Genetics |
| Darkfield Microscope |
31 |
Foundations |
| Death Phase |
99 - 100 |
Microbial Growth |
| Decimal Reduction Time (DRT) |
184 |
Control of Microbial Growth |
| Decomposition Reaction |
73 |
Microbial Metabolism |
| Degeneracy |
131 |
Microbial Genetics |
| Degerming |
183 |
Control of Microbial Growth |
| Deinococcus radiodurans |
265 |
Microbes |
| Dendritic Cells |
226 |
Disease, Immunity & Epidemiology |
| Dengue Fever |
320 |
Infections- Cardiovascular System |
| Dengue virus |
265 |
Microbes |
| Dental Caries |
341 |
Infections- Gastrointestinal System |
| Deoxyribonucleic Acid (DNA) |
27, 120 - 130 |
Foundations; Microbial Genetics |
| Dermatophytosis |
383 |
Infections- Skin & Eye System |
| Descriptive Epidemiology |
256 |
Disease, Immunity & Epidemiology |
| Dessication |
186 |
Control of Microbial Growth |
| Diagnostic Immunology |
251 |
Disease, Immunity & Epidemiology |
| Diarrheagenic E. coli |
348 |
Infections- Gastrointestinal System |
| Differential Interference Microscope |
31 |
Foundations |
| Differential Media |
114 |
Microbial Growth |
| Differential Stain |
34 - 41 |
Foundations |
| Diffusion |
67 |
Prokaryote & Eukoaryote Cells |
| Dilution Test |
203 |
Control of Microbial Growth |
| Dimorphic Fungi |
14 |
Foundations |
| Diphtheria |
293 |
Infections- Respiratory System |
| Diplobacilli |
44 |
Prokaryote & Eukoaryote Cells |
| Diplococci |
43 |
Prokaryote & Eukoaryote Cells |
| Direct Cell Count |
102 |
Microbial Growth |
| Direct Contact Transmission |
213 |
Disease, Immunity & Epidemiology |
| Direct Measurement of Bacterial Growth |
102 - 106 |
Microbial Growth |
| Direct Repair |
139 |
Microbial Genetics |
| Disease |
205 - 214 |
Disease, Immunity & Epidemiology |
| Disinfection |
183 |
Control of Microbial Growth |
| Disk-Diffusion Test |
190, 203 |
Control of Microbial Growth |
| DNA |
27, 120 - 130 |
Foundations; Microbial Genetics |
| DNA Ligase |
125 - 126 |
Microbial Genetics |
| DNA Polymerase |
124 - 126 |
Microbial Genetics |
| DNA Probe |
161 |
Microbial Genetics |
| Domain System |
6 |
Foundations |
| Donor (F+) Cells |
144 - 145 |
Microbial Genetics |
| Dosage |
192 |
Control of Microbial Growth |
| Double Replacement Reaction |
73 |
Microbial Metabolism |
| Double-Stranded DNA Virus (dsDNA) |
177 |
Acellular Infectious Agents |
| Double-Stranded RNA Virus (dsRNA) |
176 |
Acellular Infectious Agents |
| Dracunculus medinensis |
265 |
Microbes |
| Droplet Transmission |
213 |
Disease, Immunity & Epidemiology |
| Dry Heat Sterilization |
185 |
Control of Microbial Growth |
| Dyes |
34 |
Foundations |
| Ebola Disease |
322 |
Infections- Cardiovascular System |
| Ebolaviruses |
266 |
Microbes |
| Eclipse Phase |
179 - 180 |
Acellular Infectious Agents |
| Electron |
16 |
Foundations |
| Electron Carriers |
76 |
Microbial Metabolism |
| Electron Microscope |
32 |
Foundations |
| Electron Transport Chain |
89 - 91 |
Microbial Metabolism |
| Electronegativity |
17 |
Foundations |
| Emerging Infectious Diseases |
257 |
Disease, Immunity & Epidemiology |
| Encephalitis |
333 |
Infections- Nervous System |
| Endemic Disease |
254 |
Disease, Immunity & Epidemiology |
| Endergonic |
74 |
Microbial Metabolism |
| Endocytosis |
72 |
Prokaryote & Eukoaryote Cells |
| Endomembrane System |
60 |
Prokaryote & Eukoaryote Cells |
| Endoplasmic Reticulum |
60 |
Prokaryote & Eukoaryote Cells |
| Endospore Stain |
35, 41 |
Foundations |
| Endospores |
47 - 48 |
Prokaryote & Eukoaryote Cells |
| Endosymbiotic Theory |
65 - 66 |
Prokaryote & Eukoaryote Cells |
| Endotoxin |
51, 218 - 219 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
| Energy Carriers |
76 |
Microbial Metabolism |
| Enrichment Media |
114 |
Microbial Growth |
| Enterobiasis |
358 |
Infections- Gastrointestinal System |
| Enterobius vermicularis |
266 |
Microbes |
| Envelope |
165 |
Acellular Infectious Agents |
| Enzyme-Linked Immunosorbant Assay (ELISA) |
181, 251 - 252 |
Acellular Infectious Agents; Disease, Immunity & Epidemiology |
| Enzyme-Substrate Binding |
77 - 81 |
Microbial Metabolism |
| Enzymes |
77 - 81 |
Microbial Metabolism |
| Eosinophils |
226 |
Disease, Immunity & Epidemiology |
| Epidemic Disease |
254 |
Disease, Immunity & Epidemiology |
| Epidemiology |
253 - 257 |
Disease, Immunity & Epidemiology |
| Epitopes |
231 - 232 |
Disease, Immunity & Epidemiology |
| Epsilometer (E-Test) |
203 |
Control of Microbial Growth |
| Epstein Barr Virus (EBV) |
266 |
Microbes |
| Erythema Infectiousum |
380 |
Infections- Skin & Eye System |
| Escherichia coli |
267 |
Microbes |
| Etiology |
253 |
Disease, Immunity & Epidemiology |
| Eukaryotes |
6, 8, 57 - 64 |
Foundations; Prokaryote & Eukoaryote Cells |
| Exergonic |
74 |
Microbial Metabolism |
| Exocytosis |
72 |
Prokaryote & Eukoaryote Cells |
| Exoenzymes |
218 |
Disease, Immunity & Epidemiology |
| Exons |
130 |
Microbial Genetics |
| Exotoxin |
218 - 219 |
Disease, Immunity & Epidemiology |
| Experimental Epidemiology |
256 |
Disease, Immunity & Epidemiology |
| Extracellular Matrix |
63 |
Prokaryote & Eukoaryote Cells |
| F Plasmid |
144 - 145 |
Microbial Genetics |
| Facilitated Diffusion |
67 |
Prokaryote & Eukoaryote Cells |
| Facultative Anaerobes |
110 - 111 |
Microbial Growth |
| Fatty Acids |
26 |
Foundations |
| Feedback Inhibition |
80 |
Microbial Metabolism |
| Fermentation |
2, 92 - 93 |
Foundations; Microbial Metabolism |
| Fever |
229 |
Disease, Immunity & Epidemiology |
| Fever Blisters |
378 |
Infections- Skin & Eye System |
| Fifth Disease |
380 |
Infections- Skin & Eye System |
| Filtration |
186 |
Control of Microbial Growth |
| Fimbriae |
53 |
Prokaryote & Eukoaryote Cells |
| Fixation |
33 |
Foundations |
| Flagella Stain |
35 |
Foundations |
| Flagellum/Flagella |
54 - 56, 64 |
Prokaryote & Eukoaryote Cells |
| Fleming, Alexander |
3 |
Foundations |
| Fluid Mosaic Model |
49 |
Prokaryote & Eukoaryote Cells |
| Fluorescence Microscope |
32 |
Foundations |
| Fluorescent Antibody Test |
251 |
Disease, Immunity & Epidemiology |
| Fluoroquinolones |
195 |
Control of Microbial Growth |
| Focal Infection |
211 |
Disease, Immunity & Epidemiology |
| Folliculitis |
371 |
Infections- Skin & Eye System |
| Fomite |
213 |
Disease, Immunity & Epidemiology |
| Foodborne Transmission |
214 |
Disease, Immunity & Epidemiology |
| Frameshift Mutation |
136 - 137 |
Microbial Genetics |
| Freezing |
186 |
Control of Microbial Growth |
| Fungi |
6, 14 |
Foundations |
| Gardnerella vaginalis |
267 |
Microbes |
| Gastric Juice |
222 |
Disease, Immunity & Epidemiology |
| Gastroenteritis (Viral) |
354 |
Infections- Gastrointestinal System |
| Gel Electrophoresis |
159 - 160 |
Microbial Genetics |
| Gene |
123 |
Microbial Genetics |
| Gene Expression |
123 |
Microbial Genetics |
| Gene Regulation |
147 - 152 |
Microbial Genetics |
| Generalized Transduction |
142 - 143, 172 |
Microbial Genetics |
| Generation Time |
99 |
Microbial Growth |
| Genetic Code |
131 - 132 |
Microbial Genetics |
| Genetic Engineering |
153 - 163 |
Microbial Genetics |
| Genotype |
123 |
Microbial Genetics |
| Germ Theory of Disease |
3 |
Foundations |
| German Measles |
303 |
Infections- Respiratory System |
| Germination |
47 |
Prokaryote & Eukoaryote Cells |
| Giardia lamblia (Giardia duodenalis) |
268 |
Microbes |
| Giardiasis |
356 |
Infections- Gastrointestinal System |
| Glycocalyx |
53 |
Prokaryote & Eukoaryote Cells |
| Glycolysis |
83 - 85 |
Microbial Metabolism |
| Golgi Apparatus |
60 |
Prokaryote & Eukoaryote Cells |
| Gonorrhea |
363 |
Infections- Genitourinary System |
| Gram Stain |
35 - 38 |
Foundations |
| Gram-Negative Cell Walls |
51 - 52 |
Prokaryote & Eukoaryote Cells |
| Gram-Positive Cell Walls |
51 - 52 |
Prokaryote & Eukoaryote Cells |
| Granulocytes |
226 |
Disease, Immunity & Epidemiology |
| Granzymes |
226, 238 |
Disease, Immunity & Epidemiology |
| Group Translocation |
67 |
Prokaryote & Eukoaryote Cells |
| Gyrase |
124, 126 - 127 |
Microbial Genetics |
| Haemophilus influenzae |
268 |
Microbes |
| Halobacterium spp. |
268 |
Microbes |
| Halogens |
188 |
Control of Microbial Growth |
| Halophiles |
113 |
Microbial Growth |
| Halotolerant |
113 |
Microbial Growth |
| Hand, Foot, & Mouth Disease |
381 |
Infections- Skin & Eye System |
| Hansen's Disease |
332 |
Infections- Nervous System |
| Hapten |
231 |
Disease, Immunity & Epidemiology |
| Heat Fixation |
33 |
Foundations |
| Heavy Metals |
188 |
Control of Microbial Growth |
| Helicase |
124, 126 |
Microbial Genetics |
| Helicobacter pylori |
269 |
Microbes |
| Helper T Cells |
238 - 240 |
Disease, Immunity & Epidemiology |
| Hepatitis (Viral) |
355 |
Infections- Gastrointestinal System |
| Hepatitis viruses |
269 |
Microbes |
| Herd Immunity |
255 |
Disease, Immunity & Epidemiology |
| Herpes (Genital) |
366 |
Infections- Genitourinary System |
| Herpes (Oral) |
378 |
Infections- Skin & Eye System |
| Herpes simplex virus (HSV) |
270 |
Microbes |
| Herpes Zoster |
305 |
Infections- Respiratory System |
| Heterotroph |
82 |
Microbial Metabolism |
| Histoplasma capsulatum |
270 |
Microbes |
| Histoplasmosis |
306 |
Infections- Respiratory System |
| Holoenzyme |
78 - 79 |
Microbial Metabolism |
| Hooke, Robert |
1 |
Foundations |
| Horizontal Gene Transfer |
142 - 146 |
Microbial Genetics |
| Host Range |
164 |
Acellular Infectious Agents |
| Human herpesvirus type 6 |
270 |
Microbes |
| Human Immunodeficiency Virus (HIV) |
271, 323 |
Microbes; Infections- Cardiovascular System |
| Human Papillomavirus (HPV) |
271, 367 |
Microbes; Infections- Genitourinary System |
| Humoral Immunity |
230 - 237 |
Disease, Immunity & Epidemiology |
| Hydrogen Bond |
18, 20 |
Foundations |
| Hydrophilic |
19 |
Foundations |
| Hydrophobic |
19 |
Foundations |
| Hypersensitivity |
246 |
Disease, Immunity & Epidemiology |
| Hyperthermophiles |
112 |
Microbial Growth |
| Hypertonic Solution |
68 - 71 |
Prokaryote & Eukoaryote Cells |
| Hypotonic Solution |
68 - 71 |
Prokaryote & Eukoaryote Cells |
| Iatrogenic Disease |
206 |
Disease, Immunity & Epidemiology |
| IgA |
233 |
Disease, Immunity & Epidemiology |
| IgD |
233 |
Disease, Immunity & Epidemiology |
| IgE |
233 |
Disease, Immunity & Epidemiology |
| IgG |
233 |
Disease, Immunity & Epidemiology |
| IgM |
233 |
Disease, Immunity & Epidemiology |
| Immune System Disorders |
246 - 247 |
Disease, Immunity & Epidemiology |
| Immunodeficiency |
247 |
Disease, Immunity & Epidemiology |
| Impetigo |
372 |
Infections- Skin & Eye System |
| Inactivated Vaccine |
245 |
Disease, Immunity & Epidemiology |
| Incidence |
253 |
Disease, Immunity & Epidemiology |
| Inclusions |
46 |
Prokaryote & Eukoaryote Cells |
| Incubation Period |
207 - 208 |
Disease, Immunity & Epidemiology |
| Indirect Contact Transmission |
213 |
Disease, Immunity & Epidemiology |
| Indirect Measurement of Bacterial Growth |
107 |
Microbial Growth |
| Induced Mutations |
136 |
Microbial Genetics |
| Inducible Operon |
151 - 152 |
Microbial Genetics |
| Induction |
170 |
Acellular Infectious Agents |
| Infection |
205 - 214 |
Disease, Immunity & Epidemiology |
| Infectious Disease |
206 - 214 |
Disease, Immunity & Epidemiology |
| Infectious Dose (ID50) |
217 |
Disease, Immunity & Epidemiology |
| Infective Endocarditis |
311 |
Infections- Cardiovascular System |
| Inflammation |
225, 229 |
Disease, Immunity & Epidemiology |
| Influenza |
299 |
Infections- Respiratory System |
| Influenza virus |
271 |
Microbes |
| Innate Immunity |
220 - 229 |
Disease, Immunity & Epidemiology |
| Inoculation |
179 - 180 |
Acellular Infectious Agents |
| Integrase |
177 |
Acellular Infectious Agents |
| Intercalating Agents |
138 |
Microbial Genetics |
| Introns |
130 |
Microbial Genetics |
| Invasion Factors |
218 |
Disease, Immunity & Epidemiology |
| Ion |
17 |
Foundations |
| Ionic Bond |
18 |
Foundations |
| Ionizing Radiation |
138, 187 |
Microbial Genetics |
| Isoniazid |
197 |
Control of Microbial Growth |
| Isotonic Solution |
68 - 71 |
Prokaryote & Eukoaryote Cells |
| Jenner, Edward |
2 |
Foundations |
| Kirby-Bauer Disk Diffusion Test |
203 |
Control of Microbial Growth |
| Klebsiella pneumoniae |
272 |
Microbes |
| Koch, Robert |
3 - 4 |
Foundations |
| Koch's Postulates |
4 |
Foundations |
| Kreb's Cycle |
87 - 88 |
Microbial Metabolism |
| Kuru |
337 |
Infections- Nervous System |
| Lac Operon |
151 - 152 |
Microbial Genetics |
| Lactic Acid Fermentation |
92 - 93 |
Microbial Metabolism |
| Lactobacillus acidophilus |
272 |
Microbes |
| Lactoferrin |
223 |
Disease, Immunity & Epidemiology |
| Lag Phase |
99 - 100 |
Microbial Growth |
| Latent Disease |
209 |
Disease, Immunity & Epidemiology |
| Latent Viral Infection |
178 |
Acellular Infectious Agents |
| Lectin Pathway |
224 |
Disease, Immunity & Epidemiology |
| Legionella pneumophila |
272 |
Microbes |
| Legionnaires' Disease |
297 |
Infections- Respiratory System |
| Leprosy |
332 |
Infections- Nervous System |
| Leptospira spp. |
273 |
Microbes |
| Leptospirosis |
361 |
Infections- Genitourinary System |
| Light Repair |
139 |
Microbial Genetics |
| Light-Dependent Reactions |
95 |
Microbial Metabolism |
| Light-Independent Reactions |
95 |
Microbial Metabolism |
| Lincosamides |
194 |
Control of Microbial Growth |
| Lipid A |
51, 219 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
| Lipid Catabolism |
94 |
Microbial Metabolism |
| Lipids |
26 |
Foundations |
| Lipopeptides |
196 |
Control of Microbial Growth |
| Lipopolysaccharide (LPS) |
51 - 52 |
Prokaryote & Eukoaryote Cells |
| Lipoteichoic Acid |
51 - 52 |
Prokaryote & Eukoaryote Cells |
| Lister, Joseph |
3 |
Foundations |
| Listeria monocytogenes |
273 |
Microbes |
| Listeriosis |
331 |
Infections- Nervous System |
| Live Attentuated Vaccine |
245 |
Disease, Immunity & Epidemiology |
| Local Infection |
211 |
Disease, Immunity & Epidemiology |
| Log Phase |
99 - 100 |
Microbial Growth |
| Lyme Disease |
316 |
Infections- Cardiovascular System |
| Lysogenic Cycle |
170 - 171 |
Acellular Infectious Agents |
| Lysosomes |
61 |
Prokaryote & Eukoaryote Cells |
| Lysozyme |
222 |
Disease, Immunity & Epidemiology |
| Lytic Cycle |
168 - 169, 171 |
Acellular Infectious Agents |
| Macrolides |
194 |
Control of Microbial Growth |
| Macromolecules |
23 - 27 |
Foundations |
| Macrophages |
226 |
Disease, Immunity & Epidemiology |
| Magnification |
28 |
Foundations |
| Major Histocompatibility Complexes (MHCs) |
235 |
Disease, Immunity & Epidemiology |
| Malaria |
324 |
Infections- Cardiovascular System |
| Measles |
302 |
Infections- Respiratory System |
| Measles virus |
273 |
Microbes |
| Mechanical Vector |
214 |
Disease, Immunity & Epidemiology |
| Mediterranean Fever |
312 |
Infections- Cardiovascular System |
| Membrane Attack Complex (MAC) |
225 |
Disease, Immunity & Epidemiology |
| Membrane Filtration Technique |
104 |
Microbial Growth |
| Membrane Function Inhibitors |
196 |
Control of Microbial Growth |
| Membrane Transport |
67 - 72 |
Prokaryote & Eukoaryote Cells |
| Meningitis |
328 |
Infections- Nervous System |
| Mesophiles |
112 |
Microbial Growth |
| Metabolic Pathway Inhibitors |
197 |
Control of Microbial Growth |
| Methanobacterium |
274 |
Microbes |
| Microaerophiles |
110 - 111 |
Microbial Growth |
| Microbiota/Microbiome |
215 |
Disease, Immunity & Epidemiology |
| Microscopes |
28 - 32 |
Foundations |
| Minimal Bactericidial Concentration (MBC) |
203 |
Control of Microbial Growth |
| Minimal Inhibitory Concentration (MIC) |
203 |
Control of Microbial Growth |
| Mismatch Repair |
139 |
Microbial Genetics |
| Missense Mutation |
136 - 137 |
Microbial Genetics |
| Mitochondria |
62, 65 - 66 |
Prokaryote & Eukoaryote Cells |
| Mode of Action |
191 |
Control of Microbial Growth |
| Moist Heat Sterilization |
185 |
Control of Microbial Growth |
| Mold |
14 |
Foundations |
| Molecular Cloning |
154 - 158 |
Microbial Genetics |
| Monobactams |
193 |
Control of Microbial Growth |
| Monoclonal Antibodies |
248, 250 |
Disease, Immunity & Epidemiology |
| Monocytes |
226 |
Disease, Immunity & Epidemiology |
| Mononucleosis |
317 |
Infections- Cardiovascular System |
| Morbidity |
253 |
Disease, Immunity & Epidemiology |
| Mortality |
253 |
Disease, Immunity & Epidemiology |
| Most Probable Method (MPN) Method |
105 - 106 |
Microbial Growth |
| Mucociliary Escalator |
221 |
Disease, Immunity & Epidemiology |
| Mucous Membranes |
221 |
Disease, Immunity & Epidemiology |
| Multidrug Resistant Microbes |
202 |
Control of Microbial Growth |
| Mumps |
343 |
Infections- Gastrointestinal System |
| Mumps virus |
274 |
Microbes |
| Mutagen |
138 |
Microbial Genetics |
| Mutations |
136 - 141 |
Microbial Genetics |
| Mutualism |
216 |
Disease, Immunity & Epidemiology |
| Mycobacterium leprae |
274 |
Microbes |
| Mycobacterium tuberculosis |
275 |
Microbes |
| Mycolic Acid |
35, 39, 51 |
Foundations; Prokaryote & Eukoaryote Cells |
| Mycoplasma pneumoniae |
275 |
Microbes |
| Mycotoxin |
219 |
Disease, Immunity & Epidemiology |
| Naegleria fowleri |
275 |
Microbes |
| Narrow-Spectrum |
191 |
Control of Microbial Growth |
| Natural Killer Cells |
226 |
Disease, Immunity & Epidemiology |
| Necrotizing Fasciitis |
373 |
Infections- Skin & Eye System |
| Negative Stain |
34 |
Foundations |
| Negative-Sense Single-Strand RNA virus (-ssRNA) |
176 |
Acellular Infectious Agents |
| Neisseria gonorrhoeae |
276 |
Microbes |
| Neisseria meningitidis |
276 |
Microbes |
| Neurocysticercosis |
339 |
Infections- Nervous System |
| Neutral |
21 |
Foundations |
| Neutralism |
216 |
Disease, Immunity & Epidemiology |
| Neutralization |
234 |
Disease, Immunity & Epidemiology |
| Neutron |
16 |
Foundations |
| Neutrophiles |
113 |
Microbial Growth |
| Neutrophils |
226 |
Disease, Immunity & Epidemiology |
| Nitrogen Cycle |
117 - 118 |
Microbial Growth |
| Nitroimidazoles |
195 |
Control of Microbial Growth |
| Noncommunicable Disease |
206 |
Disease, Immunity & Epidemiology |
| Noncompetitive Inhibitor |
80 - 81 |
Microbial Metabolism |
| Noninfectious Disease |
206 |
Disease, Immunity & Epidemiology |
| Nonionizing Radiation |
138, 187 |
Microbial Genetics |
| Nonpolar Covalent Bond |
18 |
Foundations |
| Nonsense Codon |
131 |
Microbial Genetics |
| Nonsense Mutation |
136 - 137 |
Microbial Genetics |
| Norovirus |
276 |
Microbes |
| Nosocomial Disease |
206 |
Disease, Immunity & Epidemiology |
| Notifiable Diseases |
257 |
Disease, Immunity & Epidemiology |
| Nuclear Envelope |
58 |
Prokaryote & Eukoaryote Cells |
| Nuclear Pores |
58 |
Prokaryote & Eukoaryote Cells |
| Nucleic Acid Amplification Tests |
162 - 163, 181 |
Microbial Genetics; Acellular Infectious Agents |
| Nucleic Acid Synthesis Inhibitors |
195 |
Control of Microbial Growth |
| Nucleic Acid Vaccine |
245 |
Disease, Immunity & Epidemiology |
| Nucleic Acids |
27, 120 - 122 |
Foundations; Microbial Genetics |
| Nucleoid |
46 |
Prokaryote & Eukoaryote Cells |
| Nucleolus |
58 |
Prokaryote & Eukoaryote Cells |
| Nucleoside Analogs |
138 |
Microbial Genetics |
| Nucleosome |
58 |
Prokaryote & Eukoaryote Cells |
| Nucleotide Excision Repair |
139 |
Microbial Genetics |
| Nucleotide-Modifying Agents |
138 |
Microbial Genetics |
| Nucleotides |
27, 120 - 122 |
Foundations; Microbial Genetics |
| Nucleus |
58 |
Prokaryote & Eukoaryote Cells |
| Numerical Aperture |
28 |
Foundations |
| Obligate Aerobes |
110 - 111 |
Microbial Growth |
| Obligate Anaerobes |
110 - 111 |
Microbial Growth |
| Okazaki Fragments |
125 - 126 |
Microbial Genetics |
| Operator |
147 - 152 |
Microbial Genetics |
| Operon |
147 - 152 |
Microbial Genetics |
| Opportunistic Infection |
200, 211 |
Control of Microbial Growth; Control of Microbial Growth |
| Opsonization |
225, 234 |
Disease, Immunity & Epidemiology |
| Orgin of Replication |
97 - 98 |
Microbial Growth |
| Osmosis |
68 - 71 |
Prokaryote & Eukoaryote Cells |
| Osmotic Pressure |
68, 186 |
Prokaryote & Eukoaryote Cells; Control of Microbial Growth |
| Otitis Externa |
375 |
Infections- Skin & Eye System |
| Otitis Media |
294 |
Infections- Respiratory System |
| Oxidation Reactions |
75 |
Microbial Metabolism |
| Oxidation-Reduction Reactions |
75 |
Microbial Metabolism |
| Oxidative Phosphorlyation |
89 - 91 |
Microbial Metabolism |
| Oxygen Requirements |
110 - 111 |
Microbial Growth |
| Oxygenic Photosynthesis |
96 |
Microbial Metabolism |
| Palisades |
44 |
Prokaryote & Eukoaryote Cells |
| Pandemic Disease |
254 |
Disease, Immunity & Epidemiology |
| Papillomas |
377 |
Infections- Skin & Eye System |
| Parasites |
13 |
Foundations |
| Parasitism |
216 |
Disease, Immunity & Epidemiology |
| Parvovirus B19 |
276 |
Microbes |
| Passive Artificial Immunity |
244 |
Disease, Immunity & Epidemiology |
| Passive Natural Immunity |
244 |
Disease, Immunity & Epidemiology |
| Passive Transport |
67 - 71 |
Prokaryote & Eukoaryote Cells |
| Pasteur, Louis |
2 |
Foundations |
| Pasteurization |
2, 185 |
Foundations; Control of Microbial Growth |
| Pathogen-Associated Molecular Patterns (PAMPs) |
227 |
Disease, Immunity & Epidemiology |
| Pattern-Recognition Receptors (PRRs) |
227 |
Disease, Immunity & Epidemiology |
| Penicillins |
193 |
Control of Microbial Growth |
| Penicillium spp. |
277 |
Microbes |
| Peptic Ulcer Disease (PUD) |
351 |
Infections- Gastrointestinal System |
| Peptidoglycan |
51 - 52 |
Prokaryote & Eukoaryote Cells |
| Perforins |
226, 238 |
Disease, Immunity & Epidemiology |
| Peridontal Diseases |
342 |
Infections- Gastrointestinal System |
| Period of Convalescence |
207 - 208 |
Disease, Immunity & Epidemiology |
| Period of Decline |
207 - 208 |
Disease, Immunity & Epidemiology |
| Period of Illness |
207 - 208 |
Disease, Immunity & Epidemiology |
| Periods of an Infectious Disease |
207 - 208 |
Disease, Immunity & Epidemiology |
| Peroxisomes |
61 |
Prokaryote & Eukoaryote Cells |
| Peroxygens |
189 |
Control of Microbial Growth |
| Persistant Viral Infection |
178 |
Acellular Infectious Agents |
| Pertussis |
296 |
Infections- Respiratory System |
| pH |
21 - 22 |
Foundations |
| pH Scale |
21 - 22 |
Foundations |
| Phagocytosis |
72, 227 - 228 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
| Phase-Contrast Microscope |
31 |
Foundations |
| Phenolics |
188 |
Control of Microbial Growth |
| Phenotype |
123 |
Microbial Genetics |
| Phospholipid Bilayer |
49 - 50 |
Prokaryote & Eukoaryote Cells |
| Phospholipids |
26, 49 - 50 |
Foundations; Prokaryote & Eukoaryote Cells |
| Phosphorus Cycle |
119 |
Microbial Growth |
| Photophosphorylation |
95 |
Microbial Metabolism |
| Photoreactivation |
139 |
Microbial Genetics |
| Photosynthesis |
95 - 96 |
Microbial Metabolism |
| Phototroph |
82 |
Microbial Metabolism |
| Phylogeny |
7 |
Foundations |
| Pili/Pilus |
53 |
Prokaryote & Eukoaryote Cells |
| Pink Eye |
376 |
Infections- Skin & Eye System |
| Pinocytosis |
72 |
Prokaryote & Eukoaryote Cells |
| Pinworm |
358 |
Infections- Gastrointestinal System |
| Plague |
314 |
Infections- Cardiovascular System |
| Plasma Membrane |
49 - 50, 63 |
Prokaryote & Eukoaryote Cells |
| Plasmids |
46, 144 - 145, 156 - 158 |
Prokaryote & Eukoaryote Cells; Microbial Genetics |
| Plasmodium spp. |
277 |
Microbes |
| Plasmolysis |
69, 186 |
Prokaryote & Eukoaryote Cells; Control of Microbial Growth |
| Plate Count |
102 |
Microbial Growth |
| Plating Methods |
101 |
Microbial Growth |
| Pneumonia |
291 |
Infections- Respiratory System |
| Pneumonic Plague |
314 |
Infections- Cardiovascular System |
| Point Mutation |
136 - 137 |
Microbial Genetics |
| Polar Covalent Bond |
18 |
Foundations |
| Poliomyelitis |
336 |
Infections- Nervous System |
| Poliovirus |
277 |
Microbes |
| Poly-A Tail |
130 |
Microbial Genetics |
| Polyclonal Antibodies |
248 - 249 |
Disease, Immunity & Epidemiology |
| Polymerase Chain Reaction (PCR) |
162 - 163, 181 |
Microbial Genetics; Acellular Infectious Agents |
| Polymyxins |
196 |
Control of Microbial Growth |
| Polypeptide Antibiotics |
193 |
Control of Microbial Growth |
| Positive Stain |
34 |
Foundations |
| Positive-Sense Single-Strand RNA virus (+ssRNA) |
176 |
Acellular Infectious Agents |
| Pour Plate Method |
101 |
Microbial Growth |
| Prevalence |
253 |
Disease, Immunity & Epidemiology |
| Primary Amoebic Meningoencephalitis (PAM) |
340 |
Infections- Nervous System |
| Primary Immune Response |
243 |
Disease, Immunity & Epidemiology |
| Primary Infection |
211 |
Disease, Immunity & Epidemiology |
| Primary Transcript |
130 |
Microbial Genetics |
| Primase |
124, 126 |
Microbial Genetics |
| Prions |
182, 278 |
Acellular Infectious Agents; Microbes |
| Prodromal Period |
207 - 208 |
Disease, Immunity & Epidemiology |
| Prokaryotes |
8, 42 - 56 |
Foundations; Prokaryote & Eukoaryote Cells |
| Promoter |
147 - 148 |
Microbial Genetics |
| Proofreading |
139 |
Microbial Genetics |
| Propagated Spread |
253 |
Disease, Immunity & Epidemiology |
| Prophage |
170 |
Acellular Infectious Agents |
| Prospective Epidemiology |
256 |
Disease, Immunity & Epidemiology |
| Protease |
177 |
Acellular Infectious Agents |
| Protein Catabolism |
94 |
Microbial Metabolism |
| Protein-Synthesis Inhibitors |
194 |
Control of Microbial Growth |
| Proteins |
24 |
Foundations |
| Proteus mirabilis |
278 |
Microbes |
| Protists |
6 |
Foundations |
| Proton |
16 |
Foundations |
| Protozoa |
11 |
Foundations |
| Provirus |
177 |
Acellular Infectious Agents |
| Pseudomonas aeruginosa |
279 |
Microbes |
| Psychrophiles |
112 |
Microbial Growth |
| Psychrotrophs |
112 |
Microbial Growth |
| Pure Cultures |
3 |
Foundations |
| Purines |
120 - 122 |
Microbial Genetics |
| Pyelonephritis |
360 |
Infections- Genitourinary System |
| Pyrimidines |
120 - 122 |
Microbial Genetics |
| Quorum Sensing |
108 - 109 |
Microbial Growth |
| Rabies |
335 |
Infections- Nervous System |
| Rabies virus |
279 |
Microbes |
| Radiation |
138, 187 |
Microbial Genetics |
| Receptor-Mediated Endocytosis |
72 |
Prokaryote & Eukoaryote Cells |
| Recipent (F- Cells) |
144 - 145 |
Microbial Genetics |
| Recombinant DNA Technology |
153 - 158 |
Microbial Genetics |
| Redox Reactions |
75 |
Microbial Metabolism |
| Reduction Reactions |
75 |
Microbial Metabolism |
| Reemerging Infectious Diseases |
257 |
Disease, Immunity & Epidemiology |
| Refraction |
28 |
Foundations |
| Refrigeration |
186 |
Control of Microbial Growth |
| Regulatory Gene |
147 - 148 |
Microbial Genetics |
| Regulatory T Cells |
238 |
Disease, Immunity & Epidemiology |
| Remitting Fever |
312 |
Infections- Cardiovascular System |
| Replica Plating |
140 |
Microbial Genetics |
| Repressible Operons |
149 - 150 |
Microbial Genetics |
| Repressor |
147, 149 - 152 |
Microbial Genetics |
| Reservoir |
212 |
Disease, Immunity & Epidemiology |
| Resolution |
28 |
Foundations |
| Respiratory syncytial virus (RSV) |
280, 300 |
Microbes; Infections- Respiratory System |
| Restriction Enzymes |
154 - 156 |
Microbial Genetics |
| Retrospective Epidemiology |
256 |
Disease, Immunity & Epidemiology |
| Retrovirus |
177 |
Acellular Infectious Agents |
| Reverse Transcriptase |
177 |
Acellular Infectious Agents |
| Reversible Reaction |
73 |
Microbial Metabolism |
| Rhinoviruses |
280 |
Microbes |
| Rhizobium spp. |
280 |
Microbes |
| Ribonucleic Acid (RNA) |
27, 120, 128 - 135 |
Foundations; Microbial Genetics |
| Ribosomes |
46, 59, 133 - 135 |
Prokaryote & Eukoaryote Cells; Microbial Genetics |
| Rickettsia rickettsii |
281 |
Microbes |
| Rifamycins |
195 |
Control of Microbial Growth |
| Ringworm |
383 |
Infections- Skin & Eye System |
| RNA |
27, 120, 128 - 135 |
Foundations; Microbial Genetics |
| RNA-Dependent RNA Polymerase |
176 |
Acellular Infectious Agents |
| Rocky Mountain Spotted Fever |
315 |
Infections- Cardiovascular System |
| Roseola |
379 |
Infections- Skin & Eye System |
| Rotavirus |
281 |
Microbes |
| Route of Administration |
192 |
Control of Microbial Growth |
| Rubella |
303 |
Infections- Respiratory System |
| Rubella virus |
281 |
Microbes |
| Rubeola |
302 |
Infections- Respiratory System |
| Saccharomyces cerevisiae |
282 |
Microbes |
| Saliva |
222 |
Disease, Immunity & Epidemiology |
| Salmonella spp. |
282 |
Microbes |
| Salmonellosis |
346 |
Infections- Gastrointestinal System |
| Sanitization |
183 |
Control of Microbial Growth |
| Sarcinae |
43 |
Prokaryote & Eukoaryote Cells |
| SARS-Coronavirus-2 |
282 |
Microbes |
| Saturated Fatty Acids |
26 |
Foundations |
| Scanning Probe Microscope |
32 |
Foundations |
| Schistosoma spp. |
283 |
Microbes |
| Schistosomiasis |
327 |
Infections- Cardiovascular System |
| Sebum |
222 |
Disease, Immunity & Epidemiology |
| Secondary Immune Response |
243 |
Disease, Immunity & Epidemiology |
| Secondary Infection |
200, 211 |
Control of Microbial Growth; Control of Microbial Growth |
| Selective Media |
114 |
Microbial Growth |
| Selective Permeability |
49 |
Prokaryote & Eukoaryote Cells |
| Selective Toxicity |
191 |
Control of Microbial Growth |
| Semiconservative Replication |
124 - 126 |
Microbial Genetics |
| Sepsis |
309 |
Infections- Cardiovascular System |
| Septic Shock |
309 |
Infections- Cardiovascular System |
| Septicemic Plague |
314 |
Infections- Cardiovascular System |
| Serial Dilution |
102 - 103 |
Microbial Growth |
| Serological Assays |
181, 251 - 252 |
Acellular Infectious Agents; Disease, Immunity & Epidemiology |
| Serratia marcescens |
283 |
Microbes |
| Shigella spp. |
284 |
Microbes |
| Shigellosis |
345 |
Infections- Gastrointestinal System |
| Shingles |
305 |
Infections- Respiratory System |
| Siderophores |
218 |
Disease, Immunity & Epidemiology |
| Signs |
205 |
Disease, Immunity & Epidemiology |
| Silent Mutation |
136 - 137 |
Microbial Genetics |
| Simple Diffusion |
67 |
Prokaryote & Eukoaryote Cells |
| Simple Stain |
34 |
Foundations |
| Single Replacement Reaction |
73 |
Microbial Metabolism |
| Single-Stranded DNA virus (ssDNA) |
177 |
Acellular Infectious Agents |
| Sixth Disease |
379 |
Infections- Skin & Eye System |
| Skin |
221 |
Disease, Immunity & Epidemiology |
| Sleeping Sickness |
338 |
Infections- Nervous System |
| Slime Layer |
53 |
Prokaryote & Eukoaryote Cells |
| Smallpox |
382 |
Infections- Skin & Eye System |
| Smallpox virus |
284 |
Microbes |
| Solute |
19 |
Foundations |
| Solvent |
19 |
Foundations |
| Specialized Transduction |
142, 172 - 173 |
Microbial Genetics |
| Spikes |
165 |
Acellular Infectious Agents |
| Spirillum |
42 |
Prokaryote & Eukoaryote Cells |
| Spirochete |
42 |
Prokaryote & Eukoaryote Cells |
| Spontaenous Generation |
1 |
Foundations |
| Spontaneous Mutations |
136 |
Microbial Genetics |
| Sporadic Disease |
254 |
Disease, Immunity & Epidemiology |
| Sporulation |
47 - 48 |
Prokaryote & Eukoaryote Cells |
| Spread Plate Method |
101 |
Microbial Growth |
| Stages of Pathogenesis |
210 |
Disease, Immunity & Epidemiology |
| Stains |
34 - 41 |
Foundations |
| Staphylococcal Food Poisoning |
344 |
Infections- Gastrointestinal System |
| Staphylococci |
43 |
Prokaryote & Eukoaryote Cells |
| Staphylococcus aureus |
284 |
Microbes |
| Start Codon |
131 |
Microbial Genetics |
| Stationary Phase |
99 - 100 |
Microbial Growth |
| Sterilization |
183 |
Control of Microbial Growth |
| Sterols |
26 |
Foundations |
| Sticky Ends |
154 - 156 |
Microbial Genetics |
| Stop Codon |
131 - 132 |
Microbial Genetics |
| Streopcoccal Pharyngitis |
292 |
Infections- Respiratory System |
| Strep Throat |
292 |
Infections- Respiratory System |
| Streptobacilli |
44 |
Prokaryote & Eukoaryote Cells |
| Streptococci |
43 |
Prokaryote & Eukoaryote Cells |
| Streptococcus agalactiae |
285 |
Microbes |
| Streptococcus mutans |
285 |
Microbes |
| Streptococcus pneumoniae |
285 |
Microbes |
| Streptococcus pyogenes |
286 |
Microbes |
| Substrate |
78 - 81 |
Microbial Metabolism |
| Subunit Vaccine |
245 |
Disease, Immunity & Epidemiology |
| Sulfolobus spp. |
286 |
Microbes |
| Sulfonamides |
197 |
Control of Microbial Growth |
| Sulfur Cycle |
119 |
Microbial Growth |
| Supercritical Fluids |
189 |
Control of Microbial Growth |
| Superinfection |
200, 211 |
Control of Microbial Growth; Control of Microbial Growth |
| Surfactants |
188 |
Control of Microbial Growth |
| Sweat |
222 |
Disease, Immunity & Epidemiology |
| Swimmer's Ear |
375 |
Infections- Skin & Eye System |
| Symboiosis |
216 |
Disease, Immunity & Epidemiology |
| Symptoms |
205 |
Disease, Immunity & Epidemiology |
| Syndrome |
205 |
Disease, Immunity & Epidemiology |
| Synergism |
192 |
Control of Microbial Growth |
| Synthesis Reaction |
73 |
Microbial Metabolism |
| Syphilis |
365 |
Infections- Genitourinary System |
| Systemic Infection |
211 |
Disease, Immunity & Epidemiology |
| Taenia spp. |
287 |
Microbes |
| Taeniasis |
359 |
Infections- Gastrointestinal System |
| Taxonomy |
5 |
Foundations |
| Teichoic Acid |
51 |
Prokaryote & Eukoaryote Cells |
| Telomeres |
127 |
Microbial Genetics |
| Tetanus |
329 |
Infections- Nervous System |
| Tetracyclines |
194 |
Control of Microbial Growth |
| Tetrads |
43 |
Prokaryote & Eukoaryote Cells |
| Thermal Death Point |
185 |
Control of Microbial Growth |
| Thermal Death Time |
185 |
Control of Microbial Growth |
| Thermophiles |
112 |
Microbial Growth |
| Thymic Selection |
230 |
Disease, Immunity & Epidemiology |
| Thymine Dimers |
138 - 139, 187 |
Microbial Genetics |
| Tinea Infections |
383 |
Infections- Skin & Eye System |
| Toll-Like Receptors (TLRs) |
227 |
Disease, Immunity & Epidemiology |
| Toxic Shock Syndrome (TSS) |
310 |
Infections- Cardiovascular System |
| Toxins |
218 - 219 |
Disease, Immunity & Epidemiology |
| Toxoid Vaccine |
245 |
Disease, Immunity & Epidemiology |
| Toxoplasma gondii |
287 |
Microbes |
| Toxoplasmosis |
325 |
Infections- Cardiovascular System |
| Transcription |
128 - 130 |
Microbial Genetics |
| Transduction |
142 - 143, 172 - 173 |
Microbial Genetics |
| Transferrin |
223 |
Disease, Immunity & Epidemiology |
| Transformation |
142 - 143 |
Microbial Genetics |
| Transgenic |
153 |
Microbial Genetics |
| Transition Reaction |
86 |
Microbial Metabolism |
| Translation |
131 - 135 |
Microbial Genetics |
| Translocation |
134 - 135 |
Microbial Genetics |
| Transmissible Spongiform Encephalopathies (TSEs) |
337 |
Infections- Nervous System |
| Transposons |
146 |
Microbial Genetics |
| Treponema pallidum |
288 |
Microbes |
| Tricarboxylic Acid Cycle |
87 - 88 |
Microbial Metabolism |
| Trichomonas vaginalis |
288 |
Microbes |
| Trichomoniasis |
369 |
Infections- Genitourinary System |
| Triglycerides |
26 |
Foundations |
| Trp Operon |
149 - 150 |
Microbial Genetics |
| Trypanosoma spp. |
288 |
Microbes |
| Tuberculosis |
295 |
Infections- Respiratory System |
| Typhoid Fever |
347 |
Infections- Gastrointestinal System |
| Undulant Fever |
312 |
Infections- Cardiovascular System |
| Unsaturated Fatty Acids |
26 |
Foundations |
| Urinary Tract Infection (UTI) |
360 |
Infections- Genitourinary System |
| Use-Dilution Test |
190 |
Control of Microbial Growth |
| Vaccines |
2, 245 |
Foundations; Disease, Immunity & Epidemiology |
| Vacuoles |
61 |
Prokaryote & Eukoaryote Cells |
| Vaginal Candidiasis |
368 |
Infections- Genitourinary System |
| Valley Fever |
307 |
Infections- Respiratory System |
| Van Leeuwenhoek, Antonie |
1 |
Foundations |
| Varicella zoster virus (VZV) |
289 |
Microbes |
| Vector Transmission |
214 |
Disease, Immunity & Epidemiology |
| Vectors |
157 - 158 |
Microbial Genetics |
| Vegetative Cell |
47 |
Prokaryote & Eukoaryote Cells |
| Vehicle Transmission |
214 |
Disease, Immunity & Epidemiology |
| Vibrio |
42 |
Prokaryote & Eukoaryote Cells |
| Vibrio cholerae |
289 |
Microbes |
| Viral Growth Curve |
179 - 180 |
Acellular Infectious Agents |
| Viral Replication |
168 - 177 |
Acellular Infectious Agents |
| Viral Titer |
179 |
Acellular Infectious Agents |
| Virion |
164 |
Acellular Infectious Agents |
| Viroids |
182 |
Acellular Infectious Agents |
| Virulence |
217 - 218 |
Disease, Immunity & Epidemiology |
| Virulence Factors |
217 - 218 |
Disease, Immunity & Epidemiology |
| Virus Shapes/Structures |
166 - 167 |
Acellular Infectious Agents |
| Viruses |
15, 164 - 181 |
Foundations; Microbial Genetics |
| Warts |
377 |
Infections- Skin & Eye System |
| Water |
19 - 20 |
Foundations |
| Waterborne Transmission |
214 |
Disease, Immunity & Epidemiology |
| Weil's Disease |
361 |
Infections- Genitourinary System |
| West Nile virus |
289 |
Microbes |
| Wet Mount |
33 |
Foundations |
| Whooping Cough |
296 |
Infections- Respiratory System |
| Wobble Position |
131 |
Microbial Genetics |
| Wolbachia spp. |
290 |
Microbes |
| World Health Organization (WHO) |
257 |
Disease, Immunity & Epidemiology |
| Yeast |
14 |
Foundations |
| Yeast Infection |
368 |
Infections- Genitourinary System |
| Yellow Fever |
319 |
Infections- Cardiovascular System |
| Yellow Fever virus |
290 |
Microbes |
| Yersinia pestis |
290 |
Microbes |
| Zika |
334 |
Infections- Nervous System |
| Zika virus |
290 |
Microbes |
| Zone of Inhibition |
203 |
Control of Microbial Growth |
| Zoonotic Disease |
206 |
Disease, Immunity & Epidemiology |
